Image (8b6290e7 533f 4b49 8f00 A84e22abfb35 01)
Frindovyx Injection
Product Images NDC 83831-121
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Frindovyx (NDC 83831-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Frindovyx (cyclophosphamide) Injection, 500mg/ml (Vial Label)
This description is not available.*
Frindovyx (cyclophosphamide) Injection, 500 mg/ mL (Carton Label)
This is a description of Frindovyx™ (cyclophosphamide) Injection manufactured by Avyxa Pharma, LLC. It is a multiple-dose vial of a hazardous drug that must be diluted before intravenous use. Each vial contains 500mg of cyclophosphamide, USP, and 500mg of dehydrated alcohol, USP. The recommended dosage is specified in the prescribing information. It should be diluted with specific solutions only and stored refrigerated between 2°C to 8°C (36°F to 46°F).*
Frindovyx (cyclophosphamide) Injection, 1 G/2 mL (Vial Label)
This is a description of a pharmaceutical product containing cyclophosphamide. The product is in the form of a vial containing 1 g of cyclophosphamide. The recommended dosage and precautions are provided on the label. It is essential to dilute the product before injection with specific solutions mentioned. The vials should be stored refrigerated at a specific temperature range.*
Frindovyx (cyclophosphamide) Injection, 1 G/2 mL (Carton Label)
This text is a product label for an injectable medication called Frindovyx™ (cyclophosphamide). It includes information about dosage, dilution before intravenous use, storage requirements, cautionary notes, and the manufacturer's details. The medication is noted as a hazardous drug and recommended for prescription use only.*
Frindovyx (cyclophosphamide) Injection, 2 G/4 mL (Vial Label)
This text provides information about a medication called cyclophosphamide, USP, which is available in vials containing 2g. The recommended dosage and caution for injection are mentioned, along with the required dilution instructions. The vials need to be stored refrigerated at 2°C to 8°C for intravenous use. The medication is manufactured by Avyxa Pharma, LLC, in India. The text also includes a hazardous drug warning and a code number for the product.*
Frindovyx (cyclophosphamide) Injection, 2 G/ 4 mL (Carton Label)
This is the product label for Frindovyx™ (cyclophosphamide) Injection, a hazardous drug manufactured by Avyxa Pharma, LLC. The medication comes in a multiple-dose vial containing 2 grams in 4 mL (500 mg/mL) and must be diluted before intravenous use. It is recommended to use specific types of injections for dilution and store the vials refrigerated at 2°C to 8°C. The product should only be used as directed in the prescribing information.*
Image (8b6290e7 533f 4b49 8f00 A84e22abfb35 126 2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
